NIDA CTN Protocol 0068: Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder
Phase of Trial: Phase III
Latest Information Update: 06 Aug 2018
At a glance
- Drugs Bupropion (Primary) ; Naltrexone (Primary)
- Indications Drug abuse
- Focus Therapeutic Use
- Acronyms ADAPT-2
- 04 Dec 2017 Planned End Date changed from 1 Oct 2018 to 1 Mar 2019.
- 04 Dec 2017 Planned primary completion date changed from 1 Oct 2018 to 1 Mar 2019.
- 20 Jun 2017 Status changed from not yet recruiting to recruiting.